NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies
investors that a securities class action has been filed against
Teva Pharmaceutical Industries Limited ("Teva" or the "Company")
(NYSE: TEVA) and certain of its officers. This class action is on
behalf of a class consisting of all persons who purchased Teva
between February 10, 2015 and
November 3, 2016, both dates
inclusive (the "Class Period").
This class action seeks to recover damages against Defendants
for alleged violations of the federal securities laws under the
Securities Exchange Act of 1934 (the "Exchange Act").
The Complaint alleges that throughout the Class Period,
Defendants made false and/or misleading statements and/or failed to
disclose that: (1) Teva was involved in and/or had been involved in
conduct that would result in an antitrust investigation by the U.S.
Department of Justice and the State of Connecticut Office of the
Attorney General; (2) the DOJ investigation and the misconduct may
instigate U.S. prosecutors to file criminal charges against Teva
for alleged price manipulation; (3) as a result, Teva lacked
effective internal controls; and (4) consequently, Teva's public
statements were materially false and misleading at all relevant
times.
No Class has yet been certified in the above action. To
discuss this action, or for any questions, please visit the firm's
site: http://www.bgandg.com/teva or contact Peretz Bronstein, Esq. or his Investor Relations
Analyst, Yael Hurwitz of Bronstein,
Gewirtz & Grossman, LLC at 212-697-6484 or via email
info@bgandg.com. Those who inquire by e-mail are encouraged to
include their mailing address and telephone number. If you
suffered a loss in Teva, you have until January 5, 2017 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-teva-pharmaceutical-industries-limited-teva-and-lead-plaintiff-deadline---january-5-2017-300358184.html
SOURCE Bronstein, Gewirtz & Grossman, LLC